Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACAMUS: VIP/PACAP changes in stressed MS/CIS patients starting glatiramer acetate
2009-011088-35Phase 4Completed
- Sponsor
- Philipps-Universität Marburg
- Start
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of glatiramer acetate in multiple sclerosis (MS) and clinically isolated syndrome (CIS), sponsored by Philipps-Universität Marburg. Primary endpoint: VIP/PACAP serum concentration change. Started Feb 2010; status: completed.
02
Drugs
glatiramer acetate
03
Conditions
multiple sclerosis (MS)clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on 2009-011088-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011088-35.